Latest filing published 26 Nov 2025 for Premier, Inc., €675k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of John T. Bigalke across 2 companies, led by Premier, Inc. and Biora Therapeutics, Inc. The record holds 12 filings, for trades running from 9 December 2019 to 25 November 2025.
On the market, this insider has only sold: 4 sales, €91k in total. The rest of the record consists of 7 share grants. Since January 2025: no purchases and 3 sales on the market.
The newest entry dates from 26 November 2025: a transaction of €675k, in Premier, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations